Introduction
Laboratories have for years used evacuated glass tubes for blood collection. Plastic tubes have recently been developed in an attempt to improve the safety of blood collection and to avoid inherent hazards associated with glass, such as injuries due to broken tubes or tubes broken during centrifugation [1] . The increasing demand for plastic tubes also has an ecological basis since the amount of waste after incineration is lower than in the case of glass tubes. A change of blood collection tubes for coagulation testing raises concerns, however, because of the potential for 'in-vitro' activation of the coagulation leading to alteration of clotting times and single factor levels due to consumption. The same applies to interactions with antithrombotic drugs, as reported with the first generation of such tubes. In addition, the well-known permeability of plastics to liquids and/or gas [2] can induce modifications not only of the blood to citrate anticoagulant solution ratio (initially 9 vols/1 vol), but also of the citrate concentration (initially 0.109 or 0.129 mol/l) and could produce a drop in the pH. Since these variables were shown to have a significant impact on hemostasis test results [3, 4] and could decrease the benefit brought by the material, the effect of aging of the plastic tube needs to be evaluated.
Aim of the study
The aim of this multicenter (n ¼ 5) study was to compare the results of various hemostasis parameters measured in blood collected from untreated patients and patients on anticoagulant treatment into a new evacuated polymer tube and a traditional siliconized glass tube (considered as the reference) containing the same citrate concentration. We also evaluated the clinical relevance of any potential discrepancy. In addition, the impact of aging of the polymer tube was investigated by collecting blood samples in tubes with different shelf life.
Patients, materials and methods

Description of the tubes
The Vacuette tube (Greiner Bio-One, Kremsmü nster, Austria) is an evacuated bilayer polymer tube made of a polyethylene terephtalate outer layer and a polypropylene inner layer. Its nominal volume is 3.5 ml according to the ISO 6710.2 norm [5] . Two sodium citrate [6] . The evaluated polymer tubes and the siliconized glass tube (Vacutainer; Becton-Dickinson, Le Pont de Claix, France) have the same external dimensions (75 mm Â 13 mm), the same blood to citrate anticoagulation solution ratio (9 vols/1 vol), and the same sodium citrate concentration (0.109 or 0.129 mol/l). The volume of collected blood, however, is not identical in the polymer tubes (3.15 ml) and in the glass tubes (4.5 ml). The same lot of each type of tube was used in all of the participating centers.
Design of the study Four tubes were obtained from 60 untreated patients (n ¼ 12 in each of the five participating centers); that is, two polymer tubes and two siliconized glass tubes containing either 0.109 or 0.129 mol/l sodium citrate. All were at beginning of their shelf-life. Similarly, one beginning of shelf-life polymer tube (11 months to expiry) and one beginning of shelf-life glass tube were obtained from all of the patients on traditional anticoagulant treatments. Tubes containing the 0.129 mol/l sodium citrate concentration were evaluated in three centers and tubes containing the 0.109 mol/l sodium citrate concentration were evaluated in two other centers. In an attempt to investigate the potential impact of aging of the plastic on the test results, an additional polymer tube from another lot at the end of its shelf-life (1 month to expiry) was collected from treated patients. This was only performed in the centers evaluating the 0.109 mol/l sodium citrate concentration, since the manufacturer was unable to provide polymer tubes containing 0.129 mol/l sodium citrate from a batch at the end of its shelf-life. The sampling order of the different tubes was randomly defined.
Materials
Plasma obtained by centrifugation at 2000 Â g and 158C for 15 min, according to the current recommendations [7, 8] , was immediately analyzed for routine hemostasis assays and the remaining was stored frozen at À708C for further investigations (coagulation activation markers; see below). To evaluate the influence of the delay between centrifugation and analysis, centrifuged primary tubes were left at room temperature for up to 6 h.
Routine hemostasis tests -prothrombin time (PT), in seconds, ratio and percentage; International Normalized Ratio (INR); coagulation factor V (FV), in %; activated partial thromboplastin time (APTT), in seconds and ratio; and as anti-activated factor X (anti-FXa) activity, in International Units per milliliter -were locally performed on fresh plasma in each participating center using its own routine techniques. The reagents and the analyzers used in the different centers are detailed in Table 1 . It could be mentioned that the PT and APTT ratios, as well as the INR, were calculated using the internal normal values established in each center using its own routine procedure. Prothrombin fragment 1þ2 (F1þ2) and thrombin-antithrombin complexes (TAT) were evaluated using an enzyme-linked immunosorbent assay (Enzygnost F1þ2 micro and Enzygnost TAT micro, respectively; Dade Behring, Paris La Dé fense, France) in a single center, after the plasma samples were shipped frozen in dry ice.
Patients
Blood samples were obtained in the five participating centers from a total of 387 adult patients who were prescribed coagulation testing -that is, 168 patients on oral anticoagulant treatment (OAT), 111 patients treated with unfractionated heparin (UFH) and 108 patients treated with subcutaneous injections of various low molecular weight heparin (LMWH) derivatives for prophylaxis purposes or full-dose regimen -whereas 60 were not treated with any anticoagulant drug. Known anemic patients (hemoglobin < 8 g/dl) and pregnant women were excluded. The study was performed in accordance of the Declaration of Helsinki after the protocol was accepted by the Ethics Committee of our Institution.
Statistical analysis
Incomplete doublets/triplets/quadruplets of tubes, hemolyzed or coagulated samples and data obtained without following the protocol specifications were excluded from the study (n ¼ 12 for the whole study, 2.7%). Since most data were normally distributed, results were expressed as the mean values with standard deviation; except for TAT data, which were expressed as the median value with range. The results obtained in the different tubes were compared using the paired Student's t-test (in the case of normally distributed data) and the Mann-Whitney U-test for paired samples (in the case of non-normally distributed data). Analysis of variance was used to evaluate the time-dependent change in test results. The correlation between test results obtained in the different tubes was evaluated using the correlation coefficient (r). A P value smaller than 0.05 was considered significant. In addition, the bias analysis, evaluated according to Bland and Altman [9] , was used to test the clinical agreement between the results obtained in the different tubes. The standard deviation used to determine the acceptable limit was the one of the internal quality control of each parameter [10] : 0.63 s for the PT, 0.31 for the INR, 1.5 s for the APTT, and 0.05 IU/ml for anti-FXa activity. These values corresponded to coefficients of variation below 5% for all parameters except for the anti-FXa activity (8.5%).
Results
In untreated patients, the PT and FV level were not significantly different in polymer and in glass tubes, whereas the APTT was found to be significantly shorter in polymer than in glass tubes, whatever the citrate concentration ( Table 2) . The difference had no clinical relevance, however, when data were compared according to Bland-Altman analysis (data not shown). Significant (P < 0.01, analysis of variance) change in the test results was demonstrated for PT, APTT and FV over a 6-h period, which was of the same order of magnitude for all the studied tubes ( Table 3 ). The prolongation of APTT and the shortening of PT were actually observed, whereas FV levels were found to decrease over timebut none of these variations had any clinical relevance. Interestingly, the plasma levels of F1þ2 and TAT were significantly lower for both citrate concentrations when blood was drawn in polymer tubes rather than in glass tubes (Table 4) . Levels remained within the normal ranges, however, and the difference had no clinical relevance (Bland-Altman analysis, data not shown).
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In patients on OAT, despite a trend toward higher results in polymer tubes than in glass tubes, the INR was not significantly different in tubes containing 0.109 mol/l sodium citrate (Table 5 ). In contrast, the difference was significant (P < 0.01) in the case of tubes containing 0.129 mol/l sodium citrate ( Finally, the INR, the APTT and the anti-FXa results in polymer tubes and in glass tubes were highly correlated with r 2 in the range from 0.852 to 0.989 (data not shown).
Discussion
There have been a limited number of reports on the impact of plastic blood collection tubes on coagulation testing [11] [12] [13] [14] [15] [16] [17] [18] [19] , which were essentially limited to PT testing [11] [12] [13] [14] [15] . From the previously published studies dealing with plastic tubes from other manufacturers, it seems that differences between tubes mainly emerge in cohorts of anticoagulated patients and not in normal Results expressed as the mean AE SD for F1þ2 and as the median (range) for TAT since data were not normally distributed. All tubes were at the beginning of their shelf-life. Ã P < 0.05, ÃÃ P < 0.01, ÃÃÃ P < 0.005 polymer versus glass. Results expressed as the mean AE SD. Two centers evaluated tubes containing 0.109 mol/l sodium citrate and three centers evaluated tubes containing 0.129 mol/l sodium citrate. The effect of aging of the polymer tube on the test result was investigated using two lots of polymer tubes containing 0.109 mol/l sodium citrate at 11 months [beginning of shelf-life (BSL)] and at 1 month [end of shelf-life (ESL)] to expiry. Analytical comparison was made using the Student's t-test. Ã P < 0.05, ÃÃ P < 0.01, polymer versus glass. participants. Since difference was found to be amplified by aging of polymer tubes, it was suggested that any validation study of polymer tubes had to include a comparison between beginning of shelf-life and end of shelf-life tubes [18] . Some minor analytical differences in the results obtained in polymer tubes versus glass collection tubes were observed in the present study, whatever the sodium citrate concentration (0.109 or 0.129 mol/l). However, we demonstrated that these differences had no clinical relevance (Bland-Altman analysis) both in untreated patients and in patients on traditional anticoagulant therapy since such differences would not have resulted in a change in clinical decision or treatment. If none of the differences between polymer and glass tubes reported here had any clinical relevance, it was not the case in other reports comparing polymer tubes with glass tubes of unmentioned expiry date [11] [12] [13] [14] .
In patients on OAT, INRs were higher in polymer tubes than in glass tubes, but the difference, which had no clinical relevance (Bland-Altman analysis), was only significant in tubes containing 0.129 mol/l sodium citrate. Actually, the reagent used for INR determination was found to play a significant role since the trend toward higher INRs in polymer tubes than in glass tubes was only significant when a rabbit brain thromboplastin with a high ISI value (Neoplastine CI 10, Diagnostica Stago) was used. The opposite effect was observed when INR was evaluated using a human placental thromboplastin with a low ISI value (Thromborel S, Dade Behring, Paris La Dé fense, France). Not only the reagent origin, however, but also the preparation method and the additives could play a potential role in the reported difference in INR [13] . Significantly shorter APTTs were obtained when blood from patients on UFH was drawn in polymer tubes than in glass tubes. Such a result was already reported in the early 1980s when the shift from freedrawn plastic tubes to evacuated glass tubes was initiated [20] and at that time the authors concluded that this discrepancy indicated that evacuated glass tubes were unsuitable for monitoring heparin therapy by APTT [20] . On the other hand, the shortening of APTT that we observed in the Vacuette polymer tubes was conflicting with data recently reported using another brand of polymer tubes, which concluded higher APTT ratios and anti-Xa activities when blood was collected in polymer tubes than in glass tubes [16, 21] . These results suggest that the therapeutic range for APTT in patients on UFH could have to be adapted [22] in the case of a shift from glass to polymer tubes. Furthermore, we were unable to demonstrate any significant analytical differences between test results obtained in polymer tubes containing 0.109 mol/l sodium citrate at the beginning and end of the shelf-life in the groups of treated patients.
Finally, the plasma levels of F1þ2 and TAT were significantly lower in the polymer tubes than in the glass tubes for both citrate concentrations. This observation, which suggests a lower activation of the coagulation system in polymer tubes than in glass tubes, would indicate that the glass surface has some activating effect on the generation of thrombin despite the use of citrate as anticoagulant. Even if still controversial [23] , this was the rationale behind the recommendation of a mixture of a synthetic thrombin inhibitor (D-Phe-Pro-Argchloromethyl ketone), ethylenediamine tetraacetic acid and aprotinin as the anticoagulant solution for evaluation of coagulation activation markers at least in glass tubes [24] . Nevertheless, since conflicting data were available in the literature about the plasma levels of various markers of coagulation activation such as activated factor VII, activated factor XII or F1þ2 in polymer and in glass tubes [16, 18] , that specific point deserves to be further investigated before drawing definite conclusions.
In conclusion, our results suggest that blood samples collected into the Vacuette polymer tube (1 vol/9 vols) allow an accurate routine hemostasis testing both in untreated participants and in patients on traditional anticoagulant treatment during the whole shelf-life indicated by the manufacturer, as demonstrated by the similar results obtained in tubes containing 0.109 mol/l sodium citrate at beginning or end of the shelf-life. Altogether with the increased safety associated with the use of polymer tubes, these results suggest that shifting from evacuated glass tubes to the Vacuette polymer tubes for coagulation testing would be possible without raising any concern but the nominal price of the tube.
